• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [6756 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2022 WorkSafeBC Inpatient versus outpatient programs as treatment for PTSD
2022 WorkSafeBC Oral collagen supplements for shoulder sprain strain
2022 WorkSafeBC Convergence insufficiency and COVID-19 infection
2022 WorkSafeBC Lose-dose naltrexone as treatment for post-COVID conditions
2022 Scottish Health Technologies Group (SHTG) The Psychology Adding Value – Epilepsy Screening (PAVES) and early intervention for children and young people with epilepsy at risk of mental health problems
2022 Scottish Health Technologies Group (SHTG) A national radiology information system (RIS) for Scotland: perceived benefits and constraints to implementation
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Calcifediol (secondary hyperparathyroidism) - Benefit assessment according to §35a Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Isoflurane (sedation of mechanically ventilated patients) - Benefit assessment according to §35a Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Burosumab (X-linked hypophosphataemia) - Benefit assessment according to §35a Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Burosumab (X-linked hypophosphataemia, = 18 years) - Benefit assessment according to §35a Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Duvelisib (chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Duvelisib (follicular lymphoma) - Benefit assessment according to §35a Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dupilumab (severe asthma with type 2 inflammation) - Benefit assessment according to §35a Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Casirivimab/imdevimab (COVID-19) - Benefit assessment according to §35a Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lenvatinib (endometrial carcinoma) - Addendum to Commission A21-162]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (endometrial carcinoma) - Addendum to Commission A21-164]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Glucarpidase (toxic MTX plasma concentrations) - Assessment according to §35a SGB V (1), Sentence 11]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Voxelotor (sickle cell disease) - Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (small bowel cancer) - Benefit assessment according to §35a Social Code Book V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (bile cancer) - Benefit assessment according to § 35a SGB V]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (urothelial carcinoma, adjuvant) - Addendum to Commission A22-53]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (oesophageal carcinoma, combination with chemotherapy) - Addendum to Commission A22-54]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Number of tonsillitis episodes: evidence report for the S3 guideline on treatment of inflammatory diseases of the palatine tonsils/tonsillitis]
2022 Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Palliative care day centre service offer for users and caregivers]
2022 Canary Health Service [Effectiveness and safety of meditation]
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Folate testing. [Protocol]
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Revascularisation versus optimal medical therapy (OMT) for the treatment of chronic coronary syndrome (CCS). [Protocol]
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Denosumab (Prolia) for the treatment of osteoporosis
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Calcitonin gene-related peptide antagonists for the prevention of migraine [Protocol]
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Oral anticoagulants for prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation. [Protocol]
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Microwave ablation for liver tumours
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Hepatic and portal vein embolization prior to major hepatectomy
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Quality improvement strategies in trauma care: review and proposal of 31 novel quality indicators
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Achieving safe surgery after COVID-19 vaccination
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Impact of COVID-19, gender, race, specialty and seniority on mental health during surgical training: an international study
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Mesh versus non-mesh repair of groin hernias: a rapid review
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Update: guidelines on the preoperative diagnostic workup for COVID-19
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Stakeholders' perspectives of mobile x-ray services in support of healthcare-in-place in residential aged care facilities: a qualitative study
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Residents' perspectives of mobile X-ray services in support of healthcare-in-place in residential aged care facilities: a qualitative study.
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) The utilization and national variation of plain x-ray services by Australian residents of long-term care facilities
2022 Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) Smila Care Service
2022 Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) Monidor solution for the implementation of intravenous fluid therapy
2022 Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) Hygga Flow Enterprise Resource Planning System
2022 Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) The Orla INR Remote Monitoring
2022 Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) Unipercare service for home care and service centres
2022 Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) Suvanto Care Safety Service
2022 Canary Health Service [Artificial pancreas with dual release of insulin and pramlintide for treatment of type 1 diabetes mellitus]
2022 Canary Health Service [Influenza vaccination in children 6 to 59 months of age]
2022 Health Sciences Institute in Aragon (IACS) [Digital dermatoscopy]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Low-intensity pulsed ultrasound for the treatment of pseudarthrosis]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission "Low-intensity pulsed ultrasound for the treatment of pseudarthrosis"]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report: V21-12C: Surgical abortion: evidence report for the S3 guideline on abortion in the first trimester]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report: V21-12D: Antibiotic prophylaxis: evidence report for the S3 guideline on abortion in the first trimester]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report: V21-12F: Anti-D prophylaxis: evidence report for the S3 guideline on abortion in the first trimester]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report: V21-12G: Routine follow-up examination: evidence report for the S3 guideline on abortion in the first trimester]
2022 The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Pegcetacoplan (paroxysmal nocturnal haemoglobinuria, pretreated patients)]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Newsletter: overview of early access mechanisms and conditional refund terms]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Newsletter: experiences and lessons learned with conditional refund terms]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Newsletter: drug costs -tracking Quebec spending and trends]
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Treprostinil in chronic thromboembolic pulmonary hypertension (group 4)]
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Irreversible electroporation in pancreatic cancer]
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Digital breast tomosynthesis]
2022 Agency for Healthcare Research and Quality (AHRQ) Acute treatments for episodic migraine
2022 Agency for Healthcare Research and Quality (AHRQ) Antibody response following SARS-CoV-2 infection and implications for immunity: a living rapid review
2022 Agency for Healthcare Research and Quality (AHRQ) Diagnostic errors in the emergency department: a systematic review
2022 Agency for Healthcare Research and Quality (AHRQ) Evaluation of mental health mobile applications
2022 Agency for Healthcare Research and Quality (AHRQ) Improving rural health through telehealth-guided provider-to-provider communication
2022 Agency for Healthcare Research and Quality (AHRQ) Infection prevention and control for the emergency medical services and 911 workforce
2022 Agency for Healthcare Research and Quality (AHRQ) Management of infantile epilepsies
2022 Agency for Healthcare Research and Quality (AHRQ) Maternal and child outcomes associated with the Special Supplemental Nutrition Program for women, infants, and children (WIC)
2022 Agency for Healthcare Research and Quality (AHRQ) Models of care that include primary care for adult survivors of childhood cancer: a realist review
2022 Agency for Healthcare Research and Quality (AHRQ) Noninvasive nonpharmacological treatment for chronic pain
2022 Agency for Healthcare Research and Quality (AHRQ) Schedule of visits and televisits for routine antenatal care
2022 Agency for Healthcare Research and Quality (AHRQ) Telehealth for women's preventive services
2022 Agency for Healthcare Research and Quality (AHRQ) Transitions of care from pediatric to adult services for children with special healthcare needs
2022 Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Respiratory rehabilitation following hospitalization related to a diagnosis of COVID-19 - an update]
2022 Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Screening tools for frailty in users undergoing cardiac surgery requiring a sternotomy]
2022 Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Procalcitonin assay for optimizing the use of antibiotics in the treatment of infections]
2022 Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Anesthesia information management systems]
2022 Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Pulmonary rehabilitation in people with chronic obstructive pulmonary disease (a briefing note)]
2022 Canadian Agency for Drugs and Technologies in Health (CADTH) Adalimumab for the treatment of adults with non-infectious uveitis
2022 Canadian Agency for Drugs and Technologies in Health (CADTH) Adalimumab for the treatment of pediatric populations with non-infectious uveitis
2022 Canadian Agency for Drugs and Technologies in Health (CADTH) Peer support programs for youth mental health
2022 Canadian Agency for Drugs and Technologies in Health (CADTH) Internet-delivered cognitive behavioural therapy in the treatment of chronic non-cancer pain
2022 Canadian Agency for Drugs and Technologies in Health (CADTH) Dapagliflozin for chronic kidney disease
2022 Canadian Agency for Drugs and Technologies in Health (CADTH) Systemic thrombolysis by alteplase for acute ischemic stroke
2022 Canadian Agency for Drugs and Technologies in Health (CADTH) Systemic thrombolysis and endovascular therapy for large vessel occlusion acute ischemic stroke
2022 Institute for Clinical and Economic Review (ICER) Medications for obesity management: effectiveness and value
2022 Institute for Clinical and Economic Review (ICER) AMX0035 and oral edaravone for amyotrophic lateral sclerosis
2022 Institute for Clinical and Economic Review (ICER) Novel agents to prevent chemotherapy-induced neutropenia and other myelosuppressive effects [updated Sept 29, 2023]
2022 Institute for Clinical and Economic Review (ICER) Unsupported price increase report: unsupported price increases occurring in 2021
2022 Institute for Clinical and Economic Review (ICER) California unsupported price increase report; an evaluation of drug price increases during 2020 in California
2022 Institute for Clinical and Economic Review (ICER) The next generation of rare disease drug policy: ensuring both innovation and affordability
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cardiac monitoring with textile wearable Holter for atrial fibrillation detection after cryptogenic stroke]
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Use of indocyanine green in colorectal and hepato-biliopancreatic surgery]
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Evaluation of several vaccination strategies against rotavirus in Spain. Safety, efficacy, effectiveness and efficiency]
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Efficacy and safety of transanal irrigation in adults with bowel dysfunction]
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Systematic review on diagnosis and care of reactive attachment disorder]
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Safety and effectiveness of percutaneous tricuspid valve repair]
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Effectiveness of social distancing measures, in the context of the COVID-19]